Riik: Ameerika Ühendriigid
keel: inglise
Allikas: NLM (National Library of Medicine)
FLUOXETINE HYDROCHLORIDE (UNII: I9W7N6B1KJ) (FLUOXETINE - UNII:01K63SUP8D)
McKesson Contract Packaging
FLUOXETINE HYDROCHLORIDE
FLUOXETINE HYDROCHLORIDE 20 mg
PRESCRIPTION DRUG
Abbreviated New Drug Application
FLUOXETINE- FLUOXETINE CAPSULE MCKESSON CONTRACT PACKAGING ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE FLUOXETINE CAPSULES USP SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR FLUOXETINE CAPSULES USP. INITIAL U.S. APPROVAL: 1987 WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING_. INCREASED RISK OF SUICIDAL THINKING AND BEHAVIOR IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS TAKING ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER (MDD) AND OTHER PSYCHIATRIC DISORDERS (5.1). _WHEN USING FLUOXETINE AND OLANZAPINE IN COMBINATION, ALSO REFER TO BOXED WARNING SECTION OF THE PACKAGE INSERT FOR_ _OLANZAPINE AND FLUOXETINE HYDROCHLORIDE CAPSULES._ RECENT MAJOR CHANGES INDICATIONS AND USAGE, fluoxetine and olanzapine in combination: Depressive Episodes Associated with Bipolar I Disorder (1.5) 03/2009 DOSAGE AND ADMINISTRATION, fluoxetine and olanzapine in combination: Depressive Episodes Associated with Bipolar I Disorder (2.5) 03/2009 WARNINGS AND PRECAUTIONS: Serotonin Syndrome or Neuroleptic Malignant Syndrome (NMS)-Like Reactions (5.2) 01/2009 INDICATIONS AND USAGE Fluoxetine is a selective serotonin reuptake inhibitor indicated for: Acute and maintenance treatment of Major Depressive Disorder (MDD) in adult and pediatric patients aged 8 to 18 years (1.1) Acute and maintenance treatment of Obsessive Compulsive Disorder (OCD) in adult and pediatric patients aged 7 to 17 years (1.2 ) Acute and maintenance treatment of Bulimia Nervosa in adult patients (1.3) Acute treatment of Panic Disorder, with or without agoraphobia, in adult patients (1.4) _Fluoxetine and olanzapine in combination_ for: Acute treatment of Depressive Episodes Associated with Bipolar I Disorder in adults (1.5) DOSAGE AND ADMINISTRATION INDIC ATIO N ADULT PE DIATRIC MDD (2.1) 20 mg/day in am (initial dose) 10 to 20 mg/day (initial dose) OCD (2.2) 20 mg/day in am (initial dose) 10 mg/day (initial dose) Bulimia Nervosa (2.3) Lugege kogu dokumenti